Company | Mondelēz International, Inc. |
Ticker | MDLZ (Nasdaq) |
Upcoming Earnings Date | July 28, 2026 (After U.S. Market Close) |
Reporting Period | Q2 2026 (Quarter Ended June 30, 2026) |
Prepared Date | July 27, 2026 |
Sector ETF Benchmark | XLP (Consumer Staples Select Sector SPDR) |
Key Takeaway: The setup into Q2 is a modest beat or in-line print, with the single biggest swing factor being whether emerging markets organic growth can again outperform the Street’s cautious +1% consolidated organic revenue estimate and whether adjusted gross margin holds up better than feared despite elevated cocoa inventory costs still flowing through the P&L.
Heading into Q2 2026, the bar for MDLZ is deliberately low: consensus sits at just +0.75% organic revenue growth and adjusted EPS of $0.68, both of which management effectively set at Q1 earnings when it reaffirmed full-year guidance of flat-to-2% organic growth and flat-to-5% adjusted EPS growth on a constant-currency basis. Management’s posture has been cautiously constructive — acknowledging Middle East conflict-related cost headwinds (alternative routing, energy, packaging in unhedged markets) while expressing confidence in sequential volume improvement through the year; the June CFO transition (Amit Banati replacing Luca Zaramella, effective July 1) introduces a modest wildcard on tone but is unlikely to alter near-term guidance. Estimate revisions have drifted modestly lower since Q1 earnings — the Q2 EPS consensus has slipped from $0.678 to $0.679 (essentially flat) while the FY2026 EPS consensus has edged down slightly — suggesting the Street has already absorbed the Middle East headwind and is not pricing in incremental risk. The stock has underperformed XLP and the S&P 500 over the trailing twelve months (down ~14% vs. the market), but has recovered modestly since Q1 earnings, trading at roughly 18.8x NTM P/E — a compressed multiple that leaves room for re-rating if management can demonstrate volume inflection in North America and sustained emerging markets momentum. The key wildcard is cocoa cost phasing: Q1 absorbed a ~$350M+ headwind from high-cost inventory, and any signal that Q2 headwinds are moderating faster than expected — consistent with Nestlé’s commentary that lower cocoa costs will benefit H2 P&Ls — could be the catalyst for a meaningful guidance raise and stock re-rating.
Key Takeaway: Consensus is a low bar heading into Q2 — the Street is modeling only +0.75% organic revenue growth and $0.68 adjusted EPS, both well within the full-year guidance range. Organic revenue growth is the bigger swing factor: emerging markets have consistently surprised to the upside, and any acceleration in North America volume (which showed a positive inflection in March) could push the consolidated number meaningfully above the +1% consensus.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change (vs. Q2 2025) | FY2026 Guidance | Consensus vs. Guidance Midpoint |
Net Revenues ($B) | $10.08B | $8.98B | $9.23B | +2.7% | ~$39.9–40.1B (FY) | In line with FY range |
Organic Revenue Growth (%) | +3.0% | +5.6% | +0.75% | −24.8pp vs. PY | Flat to +2% | ~−24bp below midpoint (+1%) |
Volume/Mix (%) | −0.5% | −1.5% | −1.2% | Slight improvement YoY | Sequential improvement targeted | N/A (no explicit quarterly guidance) |
Adjusted EPS (Diluted, Operating) | $0.67 | $0.73 | $0.68 | −6.8% | Flat to +5% CC (FY) | Tracking low end of FY range |
Adj. Gross Profit ($B) | $3.09B | $3.03B | $3.02B | −0.3% | N/A (no explicit quarterly guidance) | N/A |
Sources: Net revenues, Organic growth (%), Volume/mix (%), EPS Diluted-operating ($), Gross profit/(loss)-operating — Visible Alpha Consensus and Actuals Data. FY2026 guidance from Q1 2026 earnings release (April 28, 2026).
Quarter | Reported | Consensus | Surprise (pp) | Result |
Q1 2026 | +3.0% | +0.6% | +2.4pp | Beat |
Q4 2025 | +5.1% | +4.2% | +0.9pp | Beat |
Q3 2025 | +3.4% | +3.7% | −0.3pp | Miss |
Q2 2025 | +5.6% | +5.6% | 0.0pp | In Line |
Q1 2025 | +3.1% | +3.5% | −0.4pp | Miss |
Q4 2024 | +5.2% | +5.8% | −0.6pp | Miss |
Q3 2024 | +5.4% | +4.8% | +0.6pp | Beat |
Q2 2024 | +5.6% (est.) | +5.6% (est.) | N/A | N/A |
Quarter | Reported ($) | Consensus ($) | Surprise (%) | Result |
Q1 2026 | $0.67 | $0.61 | +9.8% | Beat |
Q4 2025 | $0.72 | $0.69 | +4.3% | Beat |
Q3 2025 | $0.73 | $0.71 | +2.8% | Beat |
Q2 2025 | $0.73 | $0.69 | +5.8% | Beat |
Q1 2025 | $0.74 | $0.66 | +12.1% | Beat |
Q4 2024 | $0.65 | $0.66 | −1.5% | Miss |
Q3 2024 | $0.95 | $0.85 | +11.8% | Beat |
Q2 2024 | $0.73 (est.) | $0.69 (est.) | N/A | N/A |
Pattern: MDLZ has beaten adjusted EPS consensus in 6 of the last 7 fully reported quarters, with the sole miss in Q4 2024 driven by an unexpected cocoa cost spike; the consistent beat pattern on EPS — averaging ~+6% surprise — reflects management’s tendency to set conservative guidance and reinvest upside rather than flow it through to the bottom line.
Source: Visible Alpha Consensus and Actuals Data (EPS Diluted-operating, Organic growth %).
Key Takeaway: Management reaffirmed full-year guidance at Q1 earnings (April 28) rather than raising it, deliberately absorbing Middle East conflict cost headwinds and reinvesting any EPS upside back into the business. The only material post-earnings development was the CFO transition (Amit Banati effective July 1), which does not alter guidance but introduces a new voice on the Q2 call.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 28) | Revised Guidance | Current Consensus | Note |
FY2026 Organic Revenue Growth | Flat to +2% | — | +1.74% | Unchanged; consensus tracking near midpoint of range |
FY2026 Adjusted EPS Growth (CC) | Flat to +5% (constant currency) | — | $3.05 (FY consensus) | Unchanged; management signaled any upside would be reinvested |
FY2026 Free Cash Flow | ~$3.0B | — | ~$3.0B | Unchanged; no post-earnings update |
FX Translation Impact (FY2026) | +~2.0pp to revenue; +$0.06 to EPS | — | N/A | Based on XE.com rates as of Apr 23, 2026; subject to change |
CFO Leadership | Luca Zaramella (CFO → COO) | Amit Banati appointed CFO, effective July 1, 2026 | N/A | ↑ 8-K filed June 18, 2026; Banati joins from Kenvue/Kellanova; first earnings call as CFO |
Middle East Conflict Cost Headwind | Acknowledged; alternative routing, energy & packaging costs in unhedged markets | — | N/A | Ongoing; management “well covered” on oil/packaging for FY2026 but some regulated markets cannot hedge |
Source: Q1 2026 Earnings Release and Transcript (April 28, 2026); MDLZ 8-K filed June 18, 2026 (CFO appointment).
Key Takeaway: Estimates for Q2 2026 and FY2026 have drifted modestly lower since Q1 earnings — the Q2 EPS consensus is essentially flat while organic revenue estimates have ticked up slightly — suggesting the Street has already priced in the Middle East headwind and is not building in incremental risk. The gap between current consensus and the top of guidance is thin, meaning any positive surprise on volume or margin could prompt a guidance raise.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 5, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance Midpoint |
Organic Revenue Growth — Q2 2026 | +0.96% | +0.75% | −0.21pp | N/A (no quarterly guidance) | N/A | N/A | N/A |
Adjusted EPS — Q2 2026 | $0.678 | $0.679 | +0.1% | N/A (no quarterly guidance) | N/A | N/A | N/A |
Net Revenue — Q2 2026 | $9.25B | $9.23B | −0.2% | N/A | N/A | N/A | N/A |
Organic Revenue Growth — FY2026 | +1.84% | +1.74% | −0.10pp | Flat to +2% | Flat to +2% (unchanged) | No change | +74bp above midpoint (+1%) |
Adjusted EPS — FY2026 | $3.054 | $3.045 | −0.3% | Flat to +5% CC | Flat to +5% CC (unchanged) | No change | Tracking low-to-mid end of range |
Net Revenue — FY2026 | $40.07B | $39.99B | −0.2% | ~$39.9–40.1B (implied) | Unchanged | No change | In line with implied range |
Estimates have been remarkably stable since Q1 earnings, with only marginal downward drift of ~0.1–0.3% across all key metrics — the Street has absorbed the Middle East headwind and is not pricing in incremental downside, leaving the setup skewed toward a modest beat if emerging markets again outperform.
Source: Visible Alpha Consensus and Actuals Data (all KPIs, as-of May 5, 2026 and current). Q1 2026 Earnings Release for guidance.
Key Takeaway: Since Q1 earnings (April 28, 2026), MDLZ has underperformed both XLP and the S&P 500 on a net basis, with the stock essentially flat (+3.6% indexed) while XLP gained +2.7% and SPY gained +3.9% over the same period. The underperformance is driven primarily by multiple compression (NTM P/E contracted from ~19.2x to ~18.8x over the past month) rather than estimate cuts, suggesting sentiment — not fundamentals — is the primary headwind.
Date | MDLZ (Indexed) | XLP (Indexed) | SPY (Indexed) |
Apr 28, 2026 (Q1 Earnings) | 100.0 | 100.0 | 100.0 |
May 28, 2026 | 106.6 | 101.6 | 106.0 |
Jun 10, 2026 (Peak) | 109.6 | 102.9 | 101.9 |
Jun 18, 2026 (CFO Announcement) | 102.7 | 100.3 | 104.9 |
Jun 30, 2026 | 98.8 | 100.0 | 104.9 |
Jul 16, 2026 | 104.9 | 103.3 | 105.5 |
Jul 24, 2026 (Latest) | 103.4 | 101.3 | 103.8 |
Key Events Since Q1 Earnings:
Valuation Context: MDLZ currently trades at 18.8x NTM P/E and 13.9x NTM EV/EBITDA — both at the low end of the 5-year historical range and below the consumer staples peer group average, reflecting the market’s focus on near-term cocoa headwinds rather than the 2027 margin recovery story. Over the trailing 12 months, the stock is down ~13.5% with ~10.3% attributable to multiple compression and the remainder to modest estimate cuts.
Source: Stock Price Data (Yahoo Finance); Stock Performance Decomposition (NTM multiples).
Key Takeaway: Peer commentary from the last 60 days paints a mixed but navigable picture for MDLZ’s Q2: PepsiCo’s North America food weakness is a clear negative read-through for MDLZ’s biscuit business, but Nestlé’s strong snack/confectionery emerging markets growth and KHC’s constructive retailer tone are offsetting positives. The common thread across all three peers is that the consumer is stressed in North America but emerging markets remain resilient — a dynamic that plays to MDLZ’s geographic mix advantage.
Note: Only commentary explicitly covering the April–June 2026 reporting period or forward current-quarter conditions is included below. Prior-quarter results commentary (e.g., peers discussing their own Q1 2026 results as historical) is excluded.
Relevance to MDLZ: PEP’s North America food business is the most direct read-through to MDLZ’s North America biscuit segment. PEP’s international beverage strength and maintained full-year guidance are modestly positive signals for the broader consumer staples backdrop.
Source: PepsiCo Q2 2026 Earnings Call Transcript (July 9, 2026); Reuters, CNBC, Barron’s (July 9, 2026).
Relevance to MDLZ: Nestlé is the most direct global peer in snacks and confectionery, with significant overlap in chocolate, biscuits, and emerging markets. Nestlé’s H1 2026 results and H2 outlook are the highest-quality read-through available for MDLZ’s Q2 print.
Source: Nestlé H1/Q2 2026 Earnings Call Transcript (July 23, 2026); WSJ (July 23, 2026).
Relevance to MDLZ: KHC’s commentary at the Deutsche Bank conference covers the April–June 2026 period and provides read-through on North America consumer demand, retailer behavior, and pricing dynamics in the packaged food category.
Source: Kraft Heinz Deutsche Bank Global Consumer Conference Transcript (June 3, 2026).
Relevance to MDLZ: GIS’s commentary covers the April–June 2026 period (GIS fiscal Q4 ended May 2026) and provides read-through on North America snack category trends, consumer behavior, and the broader packaged food operating environment.
Source: General Mills Q4 FY2026 Earnings Call Transcript (July 1, 2026); General Mills Deutsche Bank Global Consumer Conference Transcript (June 4, 2026).
Peer | Commentary Date | Key Theme | MDLZ Read-Through | Direction |
PEP | Jul 9, 2026 | NA food organic sales −2%; consumer budgets tightening | NA biscuit weakness confirmed; low bar for MDLZ NA | Negative |
PEP | Jul 9, 2026 | FY2026 guidance maintained; international resilient | Supports MDLZ guidance reaffirmation posture | Positive |
NESN SW | Jul 23, 2026 | Snacks/confectionery double-digit EM volume growth | Strong EM snack demand supports MDLZ EM thesis | Positive |
NESN SW | Jul 23, 2026 | H2 margin to benefit from lower cocoa costs | Cocoa tailwind building; potential MDLZ guidance raise catalyst | Positive |
NESN SW | Jul 23, 2026 | Middle East conflict: higher transport/energy costs in H2 | Shared headwind; consistent with MDLZ Q1 commentary | Negative |
KHC | Jun 3, 2026 | SNAP reductions hitting sector; 100bps headwind | Value channel pressure for MDLZ NA biscuits | Negative |
KHC | Jun 3, 2026 | Retailer reception “extremely positive”; 2026 is margin floor | Constructive retailer dynamic; sector margin trough signal | Positive |
GIS | Jul 1, 2026 | Categories slowed ~1pt in Q4; value-seeking behavior persists | NA category softness; low bar for MDLZ NA biscuits | Negative |
GIS | Jun 4, 2026 | Volume up 1% where price invested; brand reinvestment working | Validates MDLZ’s reinvestment strategy for volume recovery | Positive |
Key Takeaway: The most important development since Q1 earnings is the CFO transition (Amit Banati, effective July 1), which introduces a new voice on the Q2 call but does not alter the strategic or financial outlook. The secondary development is the easing cocoa price environment — confirmed by both MDLZ management and Nestlé — which is the key catalyst for a potential H2 guidance raise.
Key Takeaway: Insider activity since Q1 earnings is minimal and not signaling — the only transactions on record are two small discretionary sales by the SVP, Controller & Chief Accounting Officer (Brian Stevens) in late April/early May, both executed through a trust and totaling a modest 64 shares. There are no open-market buys, no clustered selling, and no 10b5-1 plan initiations. The absence of insider buying at current depressed valuation levels is notable but not alarming given the typical quiet period ahead of earnings.
Name | Title | Transaction Type | Shares | Date | Note |
Brian Stevens | SVP, Controller & Chief Accounting Officer | Open Market Sale (Indirect/Trust) | 63 shares | Apr 30, 2026 | Discretionary; sold through trust; small size, not material |
Brian Stevens | SVP, Controller & Chief Accounting Officer | Open Market Sale (Indirect/Trust) | 1 share | May 1, 2026 | Discretionary; sold through trust; de minimis size |
No open-market buys, no 10b5-1 plan initiations, and no sales by C-suite executives (CEO, CFO, or division presidents) have been filed since Q1 earnings. The new CFO (Amit Banati, effective July 1) has not yet filed any Form 4 transactions. Overall, insider activity is quiet and provides no directional signal ahead of the Q2 print.
Source: SEC Form 4 Filings Database (filing date window: April 28 – July 27, 2026).